AI Article Synopsis
- The review highlights firibastat as a new medication for treating hypertension, focusing on its unique mechanism targeting the brain's renin angiotensin system.
- Recent clinical trials indicate that firibastat is effective and safe for both mild and resistant hypertension, making it a promising option for patients with difficult-to-treat cases.
- Firibastat represents a new therapeutic class in hypertension treatment, showing significant blood pressure reduction with minimal side effects.
Article Abstract
Purpose Of Review: The purpose of this review is to discuss the unique mechanism of firibastat, a new antihypertension medication. Hypertension continues to be a highly prevalent public health issue.
Recent Findings: Firibastat is a novel agent developed to treat hypertension. As the first member in the class of centrally acting agents to target the brain renin angiotensin system, firibastat offers new pathways to consider and enhances the regimen of agents currently available to treat hypertension. Recent clinical trials have demonstrated effectiveness and safety in mild hypertension as well as resistant hypertension. This review introduces firibastat as a new therapeutic class of treatment for hypertension focused on the renin angiotensin system in the brain. Early studies have shown a significant reduction in blood pressure with minimal side effects particularly in patients who are difficult to treat.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11906-021-01163-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!